Tanke Biosciences Corporation
Tanke Biosciences Corporation, through its subsidiary, Best Energy Monitoring LLC, engages in the energy monitoring business. The company monitors and analyses accurate, itemized, and real-time energy data. Its assets are utilized in the monitoring of energy consumption using internet of things (IoT), big data, and artificial intelligence for commercial buildings, such as food retail, quick servi… Read more
Market Cap & Net Worth: Tanke Biosciences Corporation (TNBI)
Tanke Biosciences Corporation (PINK:TNBI) has a market capitalization of $763.93K ($763.93K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #37796 globally and #12313 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tanke Biosciences Corporation's stock price $0.03 by its total outstanding shares 25464279 (25.46 Million).
Tanke Biosciences Corporation Market Cap History: 2015 to 2025
Tanke Biosciences Corporation's market capitalization history from 2015 to 2025. Data shows growth from $511.83K to $763.93K (4.39% CAGR).
Tanke Biosciences Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tanke Biosciences Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TNBI by Market Capitalization
Companies near Tanke Biosciences Corporation in the global market cap rankings as of March 18, 2026.
Key companies related to Tanke Biosciences Corporation by market ranking:
- BlackRock Inc (NYSE:BLK): Ranked #131 globally with a market cap of $139.78 Billion USD.
- Blackstone Group Inc (NYSE:BX): Ranked #245 globally with a market cap of $83.28 Billion USD.
- INVESTOR B (FRIA) O.N. (F:IVSD): Ranked #246 globally with a market cap of $83.12 Billion USD ( €80.97 Billion EUR).
- Brookfield Corp (NYSE:BN): Ranked #276 globally with a market cap of $76.43 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #131 | BlackRock Inc | NYSE:BLK | $139.78 Billion | $971.01 |
| #245 | Blackstone Group Inc | NYSE:BX | $83.28 Billion | $112.00 |
| #246 | INVESTOR B (FRIA) O.N. | F:IVSD | $83.12 Billion | €33.16 |
| #276 | Brookfield Corp | NYSE:BN | $76.43 Billion | $39.71 |
Tanke Biosciences Corporation Historical Marketcap From 2015 to 2025
Between 2015 and today, Tanke Biosciences Corporation's market cap moved from $511.83K to $ 763.93K, with a yearly change of 4.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $763.93K | +294.74% |
| 2024 | $193.53K | -94.93% |
| 2023 | $3.82 Million | +50.00% |
| 2022 | $2.55 Million | -91.80% |
| 2021 | $31.07 Million | +3966.67% |
| 2020 | $763.93K | +172.73% |
| 2019 | $280.11K | -37.14% |
| 2018 | $445.62K | +75.00% |
| 2017 | $254.64K | -33.33% |
| 2016 | $381.96K | -25.37% |
| 2015 | $511.83K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Tanke Biosciences Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $763.93K USD |
| MoneyControl | $763.93K USD |
| MarketWatch | $763.93K USD |
| marketcap.company | $763.93K USD |
| Reuters | $763.93K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.